Iron metabolism in bacterial cells: from physiological significance to a new class of antimicrobial agents

Iron metabolism in bacterial cells: from physiological significance to a new class of antimicrobial agents

Infectious complications in the respiratory tract caused by microorganisms from the Burkholderia cepacia complex are the main cause of death among patients with cystic fibrosis. Natural and acquired resistance mechanisms allow Burkholderia cepacia complex pathogens to adapt to the conditions of regu...

Full description

Bibliographic Details
Main Authors:	Kozlov A.V., Lyamin A.V., Zhestkov A.V., Gusyakova O.A., Khaliulin A.V.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2022-06-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	cystic fibrosis burkholderia cepacia complex siderophores cefiderocol
Online Access:	https://cmac-journal.ru/publication/2022/2/cmac-2022-t24-n2-p165/cmac-2022-t24-n2-p165.pdf

Similar Items

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
by: Michael M Tunney, et al.
Published: (2024-03-01)

Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina clades
by: Amy Pham, et al.
Published: (2023-11-01)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
by: Bryan A. Garcia, et al.
Published: (2018-02-01)

Community acquired Burkholderia cepacia sepsis in a patient with megaloblastic anemia: a case report and review of literature
by: M. Abraham, et al.
Published: (2022-03-01)

Burkholderia cepacia Complex Vaccines: Where Do We Go from here?
by: Gonzalo A. Pradenas, et al.
Published: (2016-04-01)

Detection for The Production of Siderophore in Burkholderia cepacia Isolated From the Rhizosphers of Some Plants and studing the Effect of the Bacterial Filtrate and Extract on Some Pathogenic Fungi
by: A. H. Mussa
Published: (2017-05-01)

Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01)

Isolation And Identification Of Burkholderia Cepacia From Respiratory Secretions In Cyctic Fibrosis Patients
by: Celin Telefian, et al.
Published: (2015-09-01)

Isolation And Identification Of Burkholderia Cepacia From Respiratory Secretions In Cyctic Fibrosis Patients
by: Celin Telefian, et al.
Published: (2015-09-01)

Synthesis of biosurfactants by bacterial cells: Heavy-metals tolerance and siderophores
by: S.O. Adebajo, et al.
Published: (2023-11-01)

Burkholderia Vaccines: Are We Moving Forward?
by: Leang-Chung eChoh, et al.
Published: (2013-02-01)

Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study
by: Vianney Gruzelle, et al.
Published: (2020-06-01)

Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients
by: Ergunay Koray, et al.
Published: (2008-06-01)

Molecular Research Comparing the Probabilities of Burkholderia Cepacia Bacterium Diagnosis Procedures
by: L Maki Al-Nasrawy, et al.
Published: (2022-04-01)

Iron Acquisition Mechanisms and Their Role in the Virulence of Burkholderia Species
by: Aaron T. Butt, et al.
Published: (2017-11-01)

Corrigendum: Iron Acquisition Mechanisms and Their Role in the Virulence of Burkholderia Species
by: Aaron T. Butt, et al.
Published: (2018-08-01)

Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: experiences from a single center in Brazil
by: Danila de Souza Carraro, et al.
Published: (2018-03-01)

Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis
by: Laura A. Porter, et al.
Published: (2011-11-01)

LUNG TRANSPLANTATION IN CYSTIC FIBROSIS PATIENT WITH CHRONIC AIRWAYS INFECTION OF BURKHOLDERIA CEPACIA (the first case in Russian Federation)
by: S. V. Gautier, et al.
Published: (2016-06-01)

Evaluation of Antibiotic Resistance of Burkholderia Species in the Last 10 Years in a Tertiary Care Hospital in Turkey
by: Eşe BAŞBULUT, et al.
Published: (2022-03-01)

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
by: David P. Speert, et al.
Published: (2002-02-01)

Serum susceptibility in clinical isolates of Burkholderia cenocepacia complex isolates: development of a growth based assay for high throughput determination
by: James Edward Arthur Zlosnik, et al.
Published: (2012-05-01)

Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre
by: Cassiana da Costa Ferreira Leite, et al.
Published: (2017-07-01)

Evaluation of Three Culture Media for Isolation of <i>Burkholderia cepacia</i> Complex from Respiratory Samples of Patients with Cystic Fibrosis
by: Emma C. L. Marrs, et al.
Published: (2021-12-01)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
by: Renée VE. Dagenais, et al.
Published: (2022-01-01)

Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance
by: Douglas Gordon Storey, et al.
Published: (2015-07-01)

Identification of Burkholderia cepacia in patients with cystic fibrosis by pulsed-field gel electrophoresis
by: Mohammad Mehdi Soltan Dallal, et al.
Published: (2014-05-01)

Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections
by: Omar M. El-Halfawy, et al.
Published: (2017-11-01)

Update on cystic fibrosis: selected aspects related to lung transplantation
by: Swiss Medical Weekly
Published: (2003-02-01)

Organisms isolated from adults with Cystic Fibrosis
by: Moore John E, et al.
Published: (2004-12-01)

In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA
by: Christi L. McElheny, et al.
Published: (2021-12-01)

Comparative Genomics of Burkholderia singularis sp. nov., a Low G+C Content, Free-Living Bacterium That Defies Taxonomic Dissection of the Genus Burkholderia
by: Peter Vandamme, et al.
Published: (2017-09-01)

Clinical case of successful resolution of bilateral pneumonia caused by Burkholderia cepacia complex in a patient with cystic fibrosis
by: D F Sergienko, et al.
Published: (2018-12-01)

New Auranofin Analogs with Antibacterial Properties against <i>Burkholderia</i> Clinical Isolates
by: Dustin Maydaniuk, et al.
Published: (2021-11-01)

A case of localized paranasal sinusitis associated with Burkholderia cenocepacia ST 1880 in a cystic fibrosis patient
by: Olga Kondratenko, et al.
Published: (2023-06-01)

Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy
by: Juan Carlos Gutiérrez Santana, et al.
Published: (2024-12-01)

Infection by Ralstonia Species in Cystic Fibrosis Patients: Identification of R. pickettii and R. mannitolilytica by Polymerase Chain Reaction
by: Tom Coenye, et al.
Published: (2002-07-01)

Structure of O-Antigen and Hybrid Biosynthetic Locus in Burkholderia cenocepacia Clonal Variants Recovered from a Cystic Fibrosis Patient
by: A.A. Hassan, et al.
Published: (2017-06-01)

Cervical osteomyelitis caused by Burkholderia cepacia after rhinoplasty
by: Lenny Weinstein, Christin A. Knowlton, Miriam A. Smith.
Published: (2008-02-01)

<i>Burkholderia pseudomallei</i> Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to <i>Burkholderia cepacia</i> Complex
by: Alexander J. Badten, et al.
Published: (2024-03-01)